Anti‐phosphatidylserine prothrombin antibodies as a predictor of the lupus anticoagulant in an all‐comer population
- 20 June 2022
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (9) , 2070-2074
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus ErythematosusThe Journal of Rheumatology, 2013
- Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid SyndromeClinical and Applied Thrombosis/Hemostasis, 2012
- Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2010
- Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis, 2009
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidityThrombosis and Haemostasis, 2006
- Ethnic and geographical variation in antiphospholipid (Hughes) syndromeAnnals of the Rheumatic Diseases, 2005
- Antiprothrombin antibodies detected in two different assay systemsThrombosis and Haemostasis, 2005
- Antibody profiles for the diagnosis of antiphospholipid syndromeThrombosis and Haemostasis, 2005
- PHOSPHATTDYL SERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODY IS EXCLUSIVE TO PATIENTS WITH LUPUS ANTICOAGULANTRheumatology, 1996